In depth
Fibromyalgia and blood tests
No blood test diagnoses fibromyalgia, and the tests you get are sent to rule other conditions out. So a full set of normal results is expected rather than disappointing. Being told everything came back normal is a narrower statement than being told nothing is wrong with you.
What the research found.
One meta-analysis looked at vitamin D supplements in fibromyalgia. The effect came out at a standardized mean difference of 0.85 for pain, across 4 trials, and 0.87 for the impact score across 4 more. The trials disagreed with each other badly, at 89 and 86.6 percent, and both true values reach within 0.20 of no effect.
A systematic review covered 22 nutrition studies in fibromyalgia, and several of them were on vitamin D. It reported that vitamin D produced a consistent drop in pain scores. It also found no significant difference after the treatment, and the pairing of those two findings is the part worth noticing.
One trial studied 46 women with fibromyalgia, where one of the two diets cut out gluten, dairy, added sugar, and ultraprocessed foods. High-sensitivity CRP didn't change in either group, and neither did the sedimentation rate. Every self-reported outcome improved a great deal all the same, which is the contrast this page rests on.
The usual age-adjusted upper limit for the sedimentation rate comes in two forms. For men, take your age and halve it, and for women, add ten first and then halve it. Applying that adjustment removed an apparent age difference entirely, in one cohort of rheumatoid arthritis patients studied for it.
What the number means.
| Test | Why it gets sent | What a normal result means | What an abnormal result means |
|---|---|---|---|
| Full blood count | To rule out anemia and other blood disorders | One cause of fatigue ruled out | Something else is going on that needs its own explanation |
| CRP and ESR | To rule out inflammatory disease | The expected finding, because fibromyalgia doesn't raise them | Look for an inflammatory or infectious cause. Age changes the ESR limit |
| Thyroid function | To rule out an underactive thyroid, which mimics fibromyalgia | That mimic ruled out | A treatable condition producing similar symptoms |
| Vitamin D | Often low in the general population and worth correcting | No deficiency to correct | A deficiency worth correcting, with a small and fragile effect on pain |
| Creatine kinase | To rule out a muscle disease when there's weakness | Muscle disease unlikely | Points at muscle rather than at widespread pain |
| ANA and rheumatoid factor | Sent when the features suggest an autoimmune disease | Autoimmune rheumatic disease less likely | Needs reading in context, since both are positive in many healthy people |
A reference range is not a target. Where a range on this page differs from the one your laboratory prints, the difference is explained above and sourced below. Where no trial has tested a target, this page says so rather than offering one.
There is no blood test for this
No blood test diagnoses fibromyalgia, because the diagnosis here is a clinical one. It's made on widespread pain lasting months, on where in the body that pain sits, and on the features that come with it, like fatigue and unrefreshing sleep. No laboratory number enters into any of that.
That has a consequence people are rarely warned about before the tests are taken. Every test you have is being sent to rule something else out, so a full set of normal results is the expected finding rather than a disappointing one. Being told everything came back normal is a narrower statement than being told nothing is wrong, and those two get mixed up constantly.
This page covers three separate things in order. It covers what the tests are for and what normal and abnormal results point at. It also covers the one measure here with trials behind it, which is vitamin D.
What the tests are excluding
Several conditions produce symptoms that overlap with fibromyalgia, and those conditions can be treated. An underactive thyroid can produce fatigue, aching, and low mood, anemia produces fatigue and breathlessness, a muscle disease produces weakness rather than pain, and inflammatory joint disease produces swelling and raised markers. Ruling each of those out properly is worth the blood.
Each of them has a test, and each normal result narrows the question rather than answering nothing. That's a genuinely useful job, and it doesn't feel like one when you're the person having the blood taken. It feels like a series of dead ends instead, one after another.
Which tests get sent depends on your own history and on your examination. Somebody with weakness gets a creatine kinase, somebody with joint swelling gets antibodies, and somebody with neither may reasonably have neither. A test sent for no particular reason produces a result that can't be interpreted afterwards.
Inflammatory markers, which should be normal
Fibromyalgia doesn't raise CRP or the sedimentation rate, which is why they get sent in the first place. So a truly raised marker doesn't fit with fibromyalgia and points at something else, either instead of it or alongside it. That's a useful thing for a test to be able to do.
The clearest indirect evidence on this site comes from a diet trial of 46 women with fibromyalgia. One of the two diets cut out gluten, dairy, added sugar, and ultraprocessed foods, and neither high-sensitivity CRP nor the sedimentation rate changed in either group. Every symptom score improved a great deal, so the symptoms moved and the blood tests did nothing.
One technical point is worth knowing about the sedimentation rate, which is that its usual upper limit rises with age. For men, take your age and halve it, and for women, add ten first and then halve it. Applying that adjustment removed an apparent age difference entirely in one rheumatoid arthritis cohort, so a mildly raised result in an older person isn't automatically meaningful.
Vitamin D, the one test with trials attached
Vitamin D is the most tested measure in this condition, and the results are less impressive than the volume of writing about them. A 2025 meta-analysis pooled four trials for pain, where the effect came out at a standardized mean difference of 0.85, and four more for the fibromyalgia impact score at 0.87. Both of those results reached significance, and only just, the pain result at a P value of 0.0148.
Read the disagreement between the trials before you read the effect sizes. It was 89 percent for pain and at 86.6 percent for the impact score, across only four small trials each. The trials disagreed with each other that much, so the pooled figures mean a good deal less than they look like they mean.
Both true values also came within 0.17 to 0.20 of no effect at all. The larger review of the field reached that place another way, reporting a consistent drop in pain scores and no significant difference after the treatment. That doesn't argue against correcting a genuine deficiency, and it does argue against expecting supplements to treat the pain.
The positive ANA problem
A positive antinuclear antibody test worries people with widespread pain, and it's a common source of confusion. So one thing is worth knowing before anything else, which is how common a positive result is in healthy people. It turns out to be a good deal commoner than most people expect.
One US population survey tested at a single 1 to 80 dilution and found 13.8 percent of people aged 12 and over were ANA positive. Among females the figure was 17.8 percent. Then take patients referred to a rheumatologist because of a positive ANA, where 24 percent got a diagnosis of an ANA-associated rheumatic disease and 26.2 percent had no evidence of any disease at all.
So a positive ANA alongside widespread pain doesn't establish an autoimmune diagnosis. It doesn't rule one out either, and it needs reading alongside what your examination shows. That is what a rheumatology assessment is there for.
What gets followed instead of a number
No marker tracks this condition, so there's nothing here to watch over time. A rheumatoid arthritis patient watches a disease activity score, and you have no equivalent of one. That's frustrating and it's also honest, and it's the reason symptom tracking gets used in place of a number.
The practical form of that is simple enough. Choose one or two things that count for you and follow those, and pain scores, sleep, and how far you can walk are the useful ones. Each of them tells you more about your own condition than any blood result does, and they're also what the trials measured.
One thing is worth mentioning, and that's a change in the picture. New pain in a single joint or a single area is one, weakness rather than pain is another, and a raised inflammatory marker is a third. Each of those is a reason to look at something on its own terms rather than adding it to an existing diagnosis.
Common misconceptions.
Myth. A blood test can diagnose fibromyalgia.
Reality. Not one of them can, because the diagnosis here is a clinical one. It rests on widespread pain, on how long that pain has lasted, and on the features that come with it. The tests that get sent exist to rule other conditions out, so a full set of normal results is the expected finding rather than a disappointing one.
Myth. Normal blood tests mean my pain isn't real.
Reality. It means the tests did the job they were sent to do. Fibromyalgia doesn't raise the inflammatory markers, it doesn't harm joints, and it doesn't make autoantibodies, so normal results are what the condition predicts. The best diet trial makes that point another way, because two blood markers didn't move at all while every symptom score improved.
Myth. My vitamin D deficiency is causing my fibromyalgia.
Reality. The pooled effect of supplements on pain reached significance and only just. Its true value reaches within 0.17 of no effect, and the four small trials disagreed with each other at 89 percent. The larger review of the field found a consistent drop in pain scores and no real difference after treatment, so correcting a shortfall is worth doing on its own terms.
Myth. A raised inflammatory marker fits with fibromyalgia.
Reality. It doesn't fit, and that's clinically useful rather than a technicality. Fibromyalgia doesn't raise CRP or the sedimentation rate, so a genuinely raised marker points at something else, either instead of the fibromyalgia or alongside it. The sedimentation rate limit does rise with age, and the usual adjustment is to halve your age for men, or to add ten and then halve it for women.
Questions patients ask.
Is there a blood test for fibromyalgia?
No, because the diagnosis is a clinical one rather than a laboratory one. It rests on widespread pain lasting months, on where in the body that pain sits, and on the features that come with it, like fatigue and unrefreshing sleep. The tests that get sent are there to rule other conditions out rather than to confirm this one.
Then why do I keep having blood tests?
Because several conditions feel like this one and can be treated, so ruling them out is worth doing properly. An underactive thyroid is one of them, anemia is another, a muscle disease is a third, and inflammatory joint disease is a fourth. A normal result removes one of those four from the question, which is a real answer.
Should my CRP or ESR be raised?
No, and a genuinely raised marker is worth investigating. Don't put it down to the fibromyalgia. Fibromyalgia doesn't raise inflammatory markers, so a raised one points at something else, either instead of the fibromyalgia or alongside it. One more thing is worth knowing about the sedimentation rate, because its usual upper limit rises with age, and the adjustment is to halve your age for men, or to add ten and then halve it for women.
What does my vitamin D level mean?
If it's low, correcting it is worth doing for your bones, whatever it does for your pain. As a treatment for fibromyalgia pain the evidence is weaker than it sounds, because one meta-analysis pooled four trials and the effect came out at 0.85. The trials disagreed with each other badly at 89 percent, the true value reaches within 0.17 of no effect, and the larger review found no significant difference after treatment.
Why is the vitamin D evidence considered weak?
Read the disagreement between the trials before you read the effect size. It was 89 percent for pain and at 86.6 percent for the impact score, across only four small trials each. Both true values also came within 0.17 to 0.20 of no effect at all, so the pooled figure means a good deal less than it looks like it means.
Would a positive ANA mean I have an autoimmune disease instead?
Not on its own, and it's a common source of confusion. One US survey tested the whole population at a single 1 to 80 dilution and found 13.8 percent of people aged 12 and over were ANA positive. Among patients sent to a rheumatologist for a positive ANA, 24 percent had an ANA-linked rheumatic disease and 26.2 percent had no disease at all.
Is there any marker that tracks how bad my fibromyalgia is?
Not one does, and the best evidence on that is indirect and clear. In the best diet trial in this condition, neither high-sensitivity CRP nor the sedimentation rate moved in either group, while every symptom score improved a great deal. So symptoms moved and the blood tests did nothing, which is why symptom diaries get used instead of a number.
References.
- Ilari S; Nucera S; Malafoglia V et al. Does Vitamin D Supplementation Impact Fibromyalgia-Related Pain? A Systematic Review and Meta-Analysis. Nutrients. 2025;17:3232. 10.3390/nu17203232Systematic review and meta-analysis
- Lowry E; Marley J; McVeigh J et al. Dietary Interventions in the Management of Fibromyalgia: A Systematic Review and Best-Evidence Synthesis. Nutrients. 2020;12:2664. 10.3390/nu12092664Systematic review with best-evidence synthesis
- Silva A; Bernardo A; de Mesquita M et al. An anti-inflammatory and low fermentable oligo, di, and monosaccharides and polyols diet improved patient reported outcomes in fibromyalgia: A randomized controlled trial. Frontiers in Nutrition. 2022;9. 10.3389/fnut.2022.856216Parallel-group randomised controlled trial
- Wepner F; Scheuer R; Schuetz-Wieser B et al. Effects of vitamin D on patients with fibromyalgia syndrome: A randomized placebo-controlled trial. Pain. 2014;155:261-268. 10.1016/j.pain.2013.10.002Randomised placebo-controlled trial
- Ranganath VK; Elashoff DA; Khanna D et al. Age adjustment corrects for apparent differences in erythrocyte sedimentation rate and C-reactive protein values at the onset of seropositive rheumatoid arthritis in younger and older patients. The Journal of rheumatology. 2005;32:1040-2. PMID 15940764Observational cohort analysis of 263 patients with early seropositive RA enrolled within 14 months of symptom onset
- Satoh M; Chan E; Ho L et al. Prevalence and sociodemographic correlates of antinuclear antibodies in the United States. Arthritis & Rheumatism. 2012;64:2319-2327. 10.1002/art.34380Cross-sectional analysis of a nationally representative population survey
- Fitch-Rogalsky C; Steber W; Mahler M et al. Clinical and Serological Features of Patients Referred through a Rheumatology Triage System because of Positive Antinuclear Antibodies. PLoS ONE. 2014;9:e93812. 10.1371/journal.pone.0093812Cross-sectional retrospective analysis of a central rheumatology triage database
This page gathers the published research on this subject into one place. The studies behind it were published between 1989 and 2026, and every figure links to the paper it came from. Those studies were peer reviewed. This summary of them was not. Dr. Sarah Luebker is reviewing these pages one at a time and has not reached this one yet, so it carries no medical review date and nothing here is her opinion or her advice to you. Each page gets updated as she reaches it. It is here in the meantime because the science is worth having in one organized place that is easy to find and easy to read. Talk to your own clinician before acting on any of it.
Across the site